.On this page, you are free to download all our published newsletters. As from July 2025, we will be publishing our newsletters via Substack. On our Substack page you’ll find the latest newsletters. Please don’t forget to subscribe.
Your donation can help changing lives!
Newsletter 27 September, 2025: “Hyperferritinemia with Iron Deficiency in MZ Patients”
Newsletter 13 September, 2025: “Join our webinar on 8 October”
Newsletter 30 August, 2025: “Vitamin D, Your Immune System, and Allergies in the MZ Population”
Vitamin D: Appendix for patients
Vitamin D: Appendix for physicians.
Newsletter 23 August, 2025: “Impaired Calcium Absorption and Vitamin D Deficiency”
Newsletter 16 August, 2025: “Functional Cholestasis in Pi*MZ:
A Hidden but Defining Feature of the MZ Liver”
Physician Addendum to newsletter of 16 August, 2025.
Newsletter 9 August, 2025: “Reduced liver capacity in MZ’s:
How the Recruitment-Secretory Block Reduces Liver Capacity Over Time”
Newsletter 26 July, 2025: “A breakthrough in understanding the MZ Liver:
New research derived from the UK Biobank”
Physician Addendum to newsletter of 26 July, 2025.
Newsletter 5 July, 2025: “Elevated Serum Alkaline Phosphatase”
Newsletter 28 June, 2025: “New curative treatment for AATD in the pipeline.
Newsletter 4 June, 2025: “The Fight for MZ Recognition”
Newsletter 24 May, 2025: “Electrolyte disruption”
Newsletter 17 May, 2025: “The Missing Link Between Alpha-1 Antitrypsin MZ
Genotype and Severe Rheumatoid Arthritis”
Newsletter 6 May, 2025: “Welcome, Dr. Fiona North to the Alpha1 MZ Foundation Team”
Newsletter 26 April, 2025: “Cystic fibrosis (CF) heterozygote in the Alpha1 MZ population”
Newsletter 19 April, 2025: “Retinal detachment in alpha-1 antitrypsin deficiency”
Newsletter 12 April, 2025: “iPaper about bronchitis in the Alpha1 MZ population”
Newsletter 5 April, 2025: “Why calcium matters for Alpha-1 MZ individuals”
Newsletter 29 March, 2025: “Update on medication”
Newsletter 22 March, 2025: “Gene editing”
Newsletter 8 March, 2025: “The role of vitamin E”
Newsletter 1 March, 2025: “Vitamin B12 impact on the brain”
Newsletter 22 February 2025: “The silent struggle: alpha-1 antitrypsin deficiency MZ, ER stress and cholesterol balance”
Newsletter 18 January 2025: “Increase of AAT using bioactive natural products”
Newsletter 11 January 2025: “How Alpha1 can lead to retinal detachment and blindness”
Newsletter 4 January 2025: “Patient story example to get your liver back in a good healthy state”
Newsletter 14 December 2024: “Alpha1 impact on serum iron status & a bit of looking back over 2024”
Newsletter 7 December 2024: “Alpha1 DNA testing by iGene”
Newsletter 30 November 2024: “Reduced bile acid secretion effects on the biliary tract”
Newsletter 23 November 2024: “Relationship between cholesterol levels and Alpha1”
Newsletter 16 November 2024: “Alpha-1 antitrypsin deficiency impact on our immune system”
Newsletter 9 November 2024: “Alpha1 MZ and type 2 diabetes”
Newsletter 2 November 2024: “Alpha1 MZ liver and our Western diet”
Newsletter 26 October 2024: “New board member; Wavelife Sciences tested RNA-editing on two humans”
Newsletter 19 October 2024: “Morbidities Summary Alpha1 SZ”
Newsletter 5 October 2024: “Alpha1 Netherlands, incl. the less known morbidities of Alpha1”
Newsletter 28 September 2024: “Air pollution impact on Alpha1 MZ & SZ patients (9/11 New York)”
Newsletter 21 September 2024: “Alpha-1 antitrypsin impact on coronavirus”
Newsletter 14 September 2024: “Skin, Eczema, Panniculitis”
Newsletter 7 September 2024: “MZ fatty liver explained”
Newsletter 31 August 2024: “Pain Medication, NSAID impact on Alpha1 MZ liver”
Newsletter 24 August 2024: “Mereo BioPharma Medication Alvelestat, inhibiting neutrophil elastase”
Newsletter 17 August 2024: “Organization Update”
Newsletter 10 August 2024: “Vit B12 Antibody & Intellia Therapeutics”
Newsletter 3 Augustus 2024: “The importance of Vitamin D for MZ’s”
Newsletter 27 July 2024: “Summary of the Alpha1 MZ disease burden”
Newsletter 20 July 2024: “Path to recognition of MZ’s”
Newsletter 13 July 2024: “Organization and research update & therapeutics”
Newsletter 6 July 2024: “Beam Therapeutics, Autism, update on intermittent pain in the liver area”
Newsletter 29 June 2024: “Intermittent pain in liver area”
Newsletter 22 June 2024: “Alpha-1 in autoimmune diseases, roles and therapeutic prospects”
Newsletter 15 June 2024: “DNA Editing therapeutics”
Newsletter 8 June 2024: “RNA Editing therapeutics”
Newsletter 1 June 2024: “RNAi therapeutics”
Newsletter 25 May 2024: “Bile acid, intestine microbiome, balsamic vinegar”
Newsletter 18 May 2024: “Genetic variation in autophagy function determines susceptibility to liver disease”
Newsletter 11 May 2024: “Connective tissue & blood vessels / aneurysm
Newsletter 4 May 2024: “Organization update; nutrition and food”
Newsletter 27 April 2024: “Chemotherapy and summary of past subjects”
Newsletter 20 April 2024: “Fatty liver”
Newsletter 13 April 2024: “Pregnancy, Cholestasis & Preeclampsia”
Newsletter 6 April 2024: “Alpha1 Antitrypsin reaction on inflammation incl Alpha1 MZ background inflammation”
Newsletter 30 March 2024: “Research update and cholestasis during pregnancy”
Newsletter 23 March 2024: “Biobank data and Serpina1 mutation variations”
Newsletter 16 March 2024: “Research progress and liver damage difference between MZ and ZZ”
Newsletter 9 March 2024: “Gut microbiota dysbiosis and MZ population worldwide”